Episode 54

On Biotech Hangout this week, hosts Daphne Zohar, Josh Schimmer, Rob Perez, Sam Fazeli and Mike Yee discuss market sentiment after the fallout from Silicon Valley Bank, possible impact of proposed SEC changes, the impact of IRA, data announcements (Nimbus, Karuna, Altimmune and 89bio), FDA happenings and more. The episode also delves into pharma patent cliffs, Moderna CEO, Stéphane Bancel’s, handling of his senate hearing on the company’s plans to increase price of Covid vaccines, antifungal drug approval and NFL as a biomarker for neurodegenerative disease. *This episode aired on March 24, 2023* Disclosure from Josh Schimmer: "Evercore ISI disclosures for the companies that I cover can be found on the Biotech Hangout homepage."